BioNTech SE (BNTX)
90.31
+2.52
(+2.87%)
USD |
NASDAQ |
May 20, 16:00
91.07
+0.76
(+0.84%)
After-Hours: 04:35
BioNTech EPS Diluted (Quarterly) : -2.461 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novavax, Inc. | -0.0581 |
| Moderna, Inc. | -3.40 |
| Biodexa Pharmaceuticals Plc | -- |
| GSK Plc | 1.149 |
| Merck & Co., Inc. | -1.715 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -622.28M |
| Revenue (Quarterly) | 138.17M |
| Total Expenses (Quarterly) | 760.45M |
| Enterprise Value | 5.685B |
| Gross Profit Margin (Quarterly) | -63.17% |
| Profit Margin (Quarterly) | -450.4% |
| Earnings Yield | -6.50% |
| Normalized Earnings Yield | -3.684 |